Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yeongyopaedok-san (YPS) is a traditional multi-component herbal medicine widely used in Korea and China for the treatment of inflammatory conditions, including upper respiratory tract infections (URTIs) and acute skin infections such as furuncles and carbuncles. The formula typically comprises a combination of several herbs, with *Forsythiae Fructus* (Yeongyo), *Lonicerae Flos*, *Platycodi Radix*, and *Schizonepetae Spica* serving as key ingredients. Pharmacological studies indicate that YPS exerts anti-inflammatory, antipyretic, and analgesic effects, primarily by suppressing the production of pro-inflammatory cytokines such as TNF-alpha and IL-6, and inhibiting inflammatory mediators like prostaglandin E2. It is often administered as a standardized granule or decoction to alleviate symptoms of the common cold, such as sore throat, fever, and headache.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yeongyopaedok-san.